TIEDEMANN ADVISORS, LLC - SPRING BK PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
TIEDEMANN ADVISORS, LLC ownership history of SPRING BK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2020$486,000
-8.8%
363,1140.0%0.02%
-17.9%
Q2 2020$533,000
+57.7%
363,1140.0%0.03%
+27.3%
Q1 2020$338,000
-49.7%
363,114
-14.6%
0.02%
-31.2%
Q4 2019$672,000
-55.3%
425,089
-2.9%
0.03%
-55.6%
Q3 2019$1,505,000
-1.1%
437,589
+6.2%
0.07%
-5.3%
Q2 2019$1,522,000
-64.8%
412,0490.0%0.08%
-62.7%
Q1 2019$4,323,000
+1.0%
412,0490.0%0.20%
-6.8%
Q4 2018$4,282,000
-13.7%
412,0490.0%0.22%
-25.5%
Q3 2018$4,964,000
+1.7%
412,0490.0%0.29%
-5.8%
Q2 2018$4,883,000
-22.9%
412,0490.0%0.31%
-27.9%
Q1 2018$6,336,000
+14.4%
412,0490.0%0.43%
+2.1%
Q4 2017$5,539,000
+13.0%
412,049
+13.8%
0.42%
+19.1%
Q2 2017$4,902,000
+77.4%
362,049
+16.6%
0.36%
+53.4%
Q1 2017$2,763,000310,4900.23%
Other shareholders
SPRING BK PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
BVF INC/IL 951,701$9,983,0001.12%
Morse Asset Management, Inc 149,175$1,565,0000.47%
SECTORAL ASSET MANAGEMENT INC 276,656$2,902,0000.35%
PARSONS CAPITAL MANAGEMENT INC/RI 276,963$2,905,0000.32%
CAXTON CORP 23,717$249,0000.23%
TIEDEMANN ADVISORS, LLC 412,049$4,323,0000.20%
Private Capital Advisors, Inc. 52,335$549,0000.17%
Pegasus Asset Management, Inc. 18,750$197,0000.16%
Hikari Power Ltd 53,536$562,0000.06%
SPHERA FUNDS MANAGEMENT LTD. 51,015$535,0000.05%
View complete list of SPRING BK PHARMACEUTICALS IN shareholders